Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial - Top-Institutions - MDSpire

Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

  • By

  • Martin B. Niederle

  • Ursula Foeger-Samwald

  • Philipp Riss

  • Andreas Selberherr

  • Christian Scheuba

  • Peter Pietschmann

  • Bruno Niederle

  • Katharina Kerschan-Schindl

  • August 26, 2019

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Surgical Endocrinology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Surgical Endocrinology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Metabolic Bone Disease
    • Clinical Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Bone Metabolism
    • Clinical Trials

  • #5

    University of Michigan
    University of Michigan

    Ann Arbor, MI

    Key Differentiators

    • Endocrinology
    • Bone Biology
    • Surgical Endocrinology

Original Source(s)

Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

  • by Martin B. Niederle, Ursula Foeger-Samwald, Philipp Riss, Andreas Selberherr, Christian Scheuba, Peter Pietschmann, Bruno Niederle, Katharina Kerschan-Schindl

  • August 26, 2019

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

BAR Could Predict Mortality After Hip Fracture

Preoperative lab ratio shows stronger association with short-term mortality risk vs other biomarkers.

OI Link to Metaphyseal Fractures Remains Unclear

Review found only one confirmed classic metaphyseal fracture and supports continued evaluation for possible abuse